References herein to �we,� �us,� �our� or �the Company� refer to Nanosphere,
Inc. unless the context specifically requires otherwise.
We are dedicated to enhancing medicine by providing targeted molecular
diagnostic tests that can lead to earlier disease detection, optimal patient
treatment and improved healthcare economics. Our platform, the Verigene� System,
enables clinicians to rapidly identify and treat the bacteria and viruses
responsible for some of the most complex, costly and deadly infectious diseases.
The Verigene System includes a bench-top molecular diagnostics workstation that
is an advanced platform for genomic and protein testing.
The Verigene System is differentiated by its ease of use, superior analytical
performance and ability to detect many targets on a single test, referred to as
�multiplexing.� It provides faster results, lower cost and less labor for